Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

HepeX-C shows efficacy in preventing HCV reinfection

April 27, 2004

Japanese approval sought for Peg-Intron plus Rebetol for chronic hepatitis C

April 26, 2004

Entecavir reduces viral levels in HBV-infected patients unresponsive to lamivudine

April 26, 2004

Two series of DHFR inhibitors/melanocortin receptor modulators for IBD and other uses

April 26, 2004

Good safety and pharmacokinetic profile of Albuferon-alpha in chronic hepatitis C patients

April 26, 2004

LB-80380 reported to reduce serum HBV DNA levels in hepatitis B patients

April 26, 2004

Novel HCV polymerase inhibitors for chronic hepatitis C therapy

April 26, 2004

Effects of hepatic and renal impairment on the pharmacokinetics of telbivudine

April 26, 2004

Antiviral effects of NM-283 in chronic hepatitis C patients

April 23, 2004

Preclinical and clinical evidence for the benefits of IDN-6556 in liver disorders

April 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.